Filed: 11/14/2024ACC: 0001420506-24-002434
📋 What this filing means
GHOST TREE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 52 equity positions with a total reported market value of $331.04M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
52
Positions
$331.04M
Total AUM (reported)
20.14M
Total Shares
Allocation by class
COM$195.96M59.2%
COM NEW$30.08M9.1%
S&P BIOTECH$29.64M9.0%
CALL$17.43M5.3%
ADR$13.10M4.0%
SHS$9.23M2.8%
COM PAR $.01$9.13M2.8%
Portfolio Concentration
Top 3$62.06M18.7%
4–10$78.37M23.7%
11–25$115.52M34.9%
Rest$75.10M22.7%
Top 3 weight
18.7%
Top 10 weight
42.4%
Voting Authority Distribution
Total shares with voting rights: 20.14M
Sole
Full voting authority
20.14M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole52
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings52
Rows:
SPDR SER TR
SOLEShares300K
TypeSH
Market value$29.64M
8.95%
Sole
300K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares348.78K
TypeSH
Market value$17.43M
5.26%
Sole
348.78K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares120K
TypeSH
Market value$14.99M
4.53%
Sole
120K
Shared
0.00
None
0.00
NOVO-NORDISK A S
SOLEShares110K
TypeSH
Market value$13.10M
3.96%
Sole
110K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares140K
TypeSH
Market value$12.95M
3.91%
Sole
140K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares135K
TypeSH
Market value$12.13M
3.66%
Sole
135K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares350K
TypeSH
Market value$11.51M
3.48%
Sole
350K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$10.01M
3.02%
Sole
750K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares250K
TypeSH
Market value$9.43M
2.85%
Sole
250K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares800K
TypeSH
Market value$9.23M
2.79%
Sole
800K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares80K
TypeSH
Market value$9.14M
2.76%
Sole
80K
Shared
0.00
None
0.00
INSMED INC
SOLEShares125K
TypeSH
Market value$9.13M
2.76%
Sole
125K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares140K
TypeSH
Market value$8.86M
2.68%
Sole
140K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares450K
TypeSH
Market value$8.66M
2.62%
Sole
450K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares190K
TypeSH
Market value$8.63M
2.61%
Sole
190K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares380K
TypeSH
Market value$7.84M
2.37%
Sole
380K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares52.50K
TypeSH
Market value$7.84M
2.37%
Sole
52.50K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares150K
TypeSH
Market value$7.67M
2.32%
Sole
150K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares150K
TypeSH
Market value$7.57M
2.29%
Sole
150K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares310K
TypeSH
Market value$7.25M
2.19%
Sole
310K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.47M
TypeSH
Market value$7.15M
2.16%
Sole
1.47M
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares375K
TypeSH
Market value$6.78M
2.05%
Sole
375K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares128.41K
TypeSH
Market value$6.47M
1.96%
Sole
128.41K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares535K
TypeSH
Market value$6.39M
1.93%
Sole
535K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares215K
TypeSH
Market value$6.13M
1.85%
Sole
215K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 300K | SH | $29.64M 8.95% | 300K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | CALL | 348.78K | SH | $17.43M 5.26% | 348.78K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 120K | SH | $14.99M 4.53% | 120K | 0.00 | 0.00 |
NOVO-NORDISK A SSOLE | ADR | 110K | SH | $13.10M 3.96% | 110K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 140K | SH | $12.95M 3.91% | 140K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 135K | SH | $12.13M 3.66% | 135K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 350K | SH | $11.51M 3.48% | 350K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 750K | SH | $10.01M 3.02% | 750K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 250K | SH | $9.43M 2.85% | 250K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 800K | SH | $9.23M 2.79% | 800K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 80K | SH | $9.14M 2.76% | 80K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 125K | SH | $9.13M 2.76% | 125K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 140K | SH | $8.86M 2.68% | 140K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 450K | SH | $8.66M 2.62% | 450K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 190K | SH | $8.63M 2.61% | 190K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 380K | SH | $7.84M 2.37% | 380K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 52.50K | SH | $7.84M 2.37% | 52.50K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 150K | SH | $7.67M 2.32% | 150K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 150K | SH | $7.57M 2.29% | 150K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 310K | SH | $7.25M 2.19% | 310K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.47M | SH | $7.15M 2.16% | 1.47M | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 375K | SH | $6.78M 2.05% | 375K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 128.41K | SH | $6.47M 1.96% | 128.41K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 535K | SH | $6.39M 1.93% | 535K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 215K | SH | $6.13M 1.85% | 215K | 0.00 | 0.00 |
Page 1 of 3